Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer

References

• GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. [homepage on the Internet]World Health Organization Available from: http://globocan.iarc.fr/Default.aspxAccessed January 20, 2014
   Google Scholar
• CummingsMCSimpsonPTReidLEMetastatic progression of breast cancer: insights from 50 years of autopsiesJ Pathol20142321233124122263
   PubMed Web of Science ®Google Scholar
• GoriSRimondiniSDe AngelisVCentral nervous system metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factorsOncologist200712776677317673608
   PubMed Web of Science ®Google Scholar
• ZagouriFSergentanisTNBartschRIntrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysisBreast Cancer Res Treat20131391132223588955
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast CancerFamilial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the diseaseLancet200135892911389139911705483
   PubMed Web of Science ®Google Scholar
• WestleyRLMayFEBA twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factorsInt J Endocrinol201363246123983688
   PubMed Web of Science ®Google Scholar
• AllenNEBeralVCasabonneDMillion Women Study Collaborators. Moderate alcohol intake and cancer incidence in womenJ Natl Cancer Inst2009101529630519244173
   PubMed Web of Science ®Google Scholar
• McCulloughLEEngSMBradshawPTFat or fit: the joint effects of physical activity, weight gain, and body size on breast cancer riskCancer2012118194860486822733561
   PubMed Web of Science ®Google Scholar
• SchneiderGKirschnerMABerkowitzRErtelNHIncreased estrogen production in obese menJ Clin Endocr Metab1979484633638429508
   PubMed Web of Science ®Google Scholar
• LamarCADorganJFLongcopeCStanczykFZFalkRTStephensonHEJrSerum sex hormones and breast cancer risk factors in postmenopausal womenCancer Epidemiol Biomarkers Prev200312438038312692114
   PubMed Web of Science ®Google Scholar
• JohnsonRHChienFLBleyerAIncidence of breast cancer with distant involvement among women in the United States, 1976 to 2009JAMA2013309880080523443443
   PubMed Web of Science ®Google Scholar
• SestakICuzickJPreventive therapy for breast cancerCurr Oncol Rep201214656857322972612
   PubMed Web of Science ®Google Scholar
• CuzickJSestakIBonanniBSERM Chemoprevention of Breast Cancer Overview Group. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant dataLancet201338198801827183423639488
   PubMed Web of Science ®Google Scholar
• WilliamsPTBreast cancer mortality vs exercise and breast size in runners and walkersPlos One2013812e8061624349006
   PubMed Web of Science ®Google Scholar
• JørgensenKJ1GøtzschePCOverdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trendsBMJ2009339
   Google Scholar
• Independent UK Panel on Breast Cancer ScreeningThe benefits and harms of breast cancer screening: an independent reviewLancet201238098551778178623117178
   PubMed Web of Science ®Google Scholar
• BaumMHarms from breast cancer screening outweigh benefits if death caused by treatment is includedBMJ2013346f38523344314
   PubMed Web of Science ®Google Scholar
• HeyesGJMillAJCharlesMWMammography-oncogenecity at low dosesJ Radiol Prot2009292AA123A13219454801
   PubMed Web of Science ®Google Scholar
• Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists’ Collaborative GroupN Engl J Med198831926168116923205265
   PubMed Web of Science ®Google Scholar
• Tamoxifen for early breast cancer: an overview of the randomised trialsEarly Breast Cancer Trialists’ Collaborative GroupLancet19983519114145114679605801
   PubMed Web of Science ®Google Scholar
• SestakIDistlerWForbesJFDowsettMHowellACuzickJEffect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trialJ Clin Oncol201028213411341520547990
   PubMed Web of Science ®Google Scholar
• HershmanDLKushiLHShaoTEarly discontinuation and non-adherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patientsJ Clin Oncol201028274120412820585090
   PubMed Web of Science ®Google Scholar
• van Herk-SukelMPPvan de Poll-FranseLVVoogdACNieuwenhuijzenGAPCoeberghJWWHeringsRMCHalf of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysisBreast Cancer Res Treat2010122384385120058066
   PubMed Web of Science ®Google Scholar
• DaviesCPanHGodwinJAdjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative GroupLong-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialLancet2013381986980581623219286
   PubMed Web of Science ®Google Scholar
• MillerKDDierasVHarbeckNPhase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive, Locally Advanced, or Metastatic Breast CancerJ Clin Oncol Epub 2014 April 14
   Web of Science ®Google Scholar
• WelslauMDierasVSohnJHPatient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancerCancer2014120564265124222194
   PubMed Web of Science ®Google Scholar
• RiosJPuhallaSPARP inhibitors in breast cancer: BRCA and beyondOncology201125111014102522106552
   PubMed Web of Science ®Google Scholar
• ArteagaCLSliwkowskiMXOsborneCKPerezEAPuglisiFGianniLTreatment of HER2-positive breast cancer: current status and future perspectivesNat Rev Clin Oncol201291163222124364
   PubMed Web of Science ®Google Scholar
• YardenYPinesGThe ERBB network: at last, cancer therapy meets systems biologyNat Rev Cancer201212855356322785351
   PubMed Web of Science ®Google Scholar
• TebbuttNPedersenMWJohnsTGTargeting the ERBB family in cancer: couples therapyNat Rev Cancer201313966367323949426
   PubMed Web of Science ®Google Scholar
• ClemmonsDRModifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancerNature Rev Drug Discov200761082183317906644
   PubMed Web of Science ®Google Scholar
• StewartAJJohnsonMDMayFEBWestleyBRRole of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cellsJ Biol Chem19902653421172211782174437
   PubMed Web of Science ®Google Scholar
• DavisonZde BlacquièreGEWestleyBRMayFEBInsulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapyNeoplasia201113650451521677874
   PubMed Web of Science ®Google Scholar
• WestleyBRClaytonSJDawsMRMolloyCAMayFEBInteractions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferationBiochem Soc Symp19986335449513709
   PubMedGoogle Scholar
• PollakMThe insulin and insulin-like growth factor receptor family in neoplasia: an updateNat Rev Cancer201212315916922337149
   PubMed Web of Science ®Google Scholar
• ZardavasDBaselgaJPiccartMEmerging targeted agents in metastatic breast cancerNat Rev Clin Oncol201310419121023459626
   PubMed Web of Science ®Google Scholar
• ZardavasDFumagalliDLoiSPhosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway inhibition: a breakthrough in the management of luminal (ER+/HER2-) breast cancers?Curr Opin Oncol201224662363422960556
   PubMed Web of Science ®Google Scholar
• HatzivassiliouGHalingJRChenHFMechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancersNature2013501746623223623934108
   PubMed Web of Science ®Google Scholar
• BendellJCRodonJBurrisHAPhase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumorsJ Clin Oncol201230328229022162589
   PubMed Web of Science ®Google Scholar
• IbrahimYHGarcía-GarcíaCSerraVPI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibitionCancer Discov20122111036104722915752
   PubMed Web of Science ®Google Scholar
• GucalpATolaneySIsakoffSJTranslational Breast Cancer Research Consortium (TBCRC 011)Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancerClin Cancer Res201319195505551223965901
   PubMed Web of Science ®Google Scholar
• MusgroveEACaldonCEBarracloughJStoneASutherlandRLCyclin D as a therapeutic target in cancerNat Rev Cancer201111855857221734724
   PubMed Web of Science ®Google Scholar
• PandyaKMeekeKClementzAGTargeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrenceBr J Cancer2011105679680621847123
   PubMed Web of Science ®Google Scholar
• HuangEHSinghBCristofanilliMA CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancerJ Surg Res2009155223123619482312
   PubMed Web of Science ®Google Scholar
• DesgrosellierJSChereshDAIntegrins in cancer: biological implications and therapeutic opportunitiesNat Rev Cancer201010192220029421
   PubMed Web of Science ®Google Scholar
• WongCCLZhangHFGilkesDMInhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasisJ Mol Med (Berl)201290780381522231744
   PubMed Web of Science ®Google Scholar
• JacobsonHIGuptaGNFernandezCHennixSJensenEVDetermination of tritium in biological materialArch Biochem Biophys196086899314406409
   PubMed Web of Science ®Google Scholar
• BlairRMFangHBranhamWSThe estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligandsToxicol Sci200054113815310746941
   PubMed Web of Science ®Google Scholar
• MayFEBWestleyBRIdentification and characterization of estrogen-regulated Rnas in human-breast cancer-cellsJ Biol Chem19882632612901129082458337
   PubMed Web of Science ®Google Scholar
• WrightPKMayFEBDarbySSaifRLennardTWJWestleyBREstrogen regulates vesicle trafficking gene expression in EFF-3, EFM-19 and MCF-7 breast cancer cellsInt J Clin Exp Pathol20092546347519294005
   PubMed Web of Science ®Google Scholar
• XuJMWuRCO’MalleyBWNormal and cancer-related functions of the p160 steroid receptor co-activator (SRC) familyNat Rev Cancer20099961563019701241
   PubMed Web of Science ®Google Scholar
• ManavathiBDeyOGajulapalliVNRBhatiaRSBugideSKumarRDerailed estrogen signaling and breast cancer: an authentic coupleEndocr Rev201334113222947396
   PubMed Web of Science ®Google Scholar
• Le RomancerMPoulardCCohenPSentisSRenoirJMCorboLCracking the estrogen receptor’s posttranslational code in breast tumorsEndocr Rev201132559762221680538
   PubMed Web of Science ®Google Scholar
• WalterPGreenSGreeneGCloning of the human estrogen-receptor cDNAProc Natl Acad Sci U S A19858223788978933865204
   PubMed Web of Science ®Google Scholar
• GreenSWalterPGreeneGCloning of the human estrogen-receptor cDNAJ Steroid Biochem198624177832422449
   PubMedGoogle Scholar
• KuiperGGJMEnmarkEPelto-HuikkoMNilssonSGustafssonJACloning of a novel estrogen receptor expressed in rat prostate and ovaryProc Natl Acad Sci U S A19969312592559308650195
   PubMed Web of Science ®Google Scholar
• GiguèreVYangNSeguiPEvansRMIdentification of a new class of steroid-hormone receptorsNature1988331615191943267207
   PubMed Web of Science ®Google Scholar
• ChenFZhangQMcDonaldTIdentification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCRGene19992281–210110910072763
   PubMed Web of Science ®Google Scholar
• SchwabeJWRChapmanLFinchJTRhodesDThe crystal-structure of the estrogen-receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elementsCell19937535675788221895
   PubMed Web of Science ®Google Scholar
• Klein-HitpassLSchorppMWagnerURyffelGUAn estrogen-responsive element derived from the 5′ flanking region of the xenopus vitellogenin A2 gene functions in transfected human-cellsCell1986467105310613463433
   PubMed Web of Science ®Google Scholar
• MayFEBSmithDJWestleyBRThe human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start pointGene199313422772828262386
   PubMed Web of Science ®Google Scholar
• BerryMNunezAMChambonPEstrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequenceProc Natl Acad Sci U S A1989864121812222919170
   PubMed Web of Science ®Google Scholar
• MayFEBWestleyBREstrogen regulated messenger RNAs in human breast cancer cellsBiomed Pharmacother19954994004148746076
   PubMed Web of Science ®Google Scholar
• KlingeCMEstrogen receptor interaction with estrogen response elementsNucleic Acids Res200129142905291911452016
   PubMed Web of Science ®Google Scholar
• MayFEBWestleyBRCloning of estrogen-regulated messenger RNA sequences from human breast cancer cellsCancer Res19864612603460402430688
   PubMed Web of Science ®Google Scholar
• PrestSJMayFEBWestleyBRThe estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cellsFASEB J200216259259411919164
   PubMed Web of Science ®Google Scholar
• YangNYShigetaHShiHPTengCTEstrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoterJ Biol Chem199627110579558048621448
   PubMed Web of Science ®Google Scholar
• VanackerJMDelmarreCGuoXJLaudetVActivation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alphaCell Growth Differ1998912100710149869301
   PubMedGoogle Scholar
• VanackerJMBonnelyeEDelmarreCLaudetVActivation of the thyroid hormone receptor alpha gene promoter by the orphan nuclear receptor ERR alphaOncogene19981719242924359824153
   PubMed Web of Science ®Google Scholar
• YangCZhouDJChenSModulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptorCancer Res19985824569557009865725
   PubMed Web of Science ®Google Scholar
• LuDSKiriyamaYLeeKYGiguèreVTranscriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptorsCancer Res200161186755676111559547
   PubMed Web of Science ®Google Scholar
• BrzozowskiAMPikeACWDauterZMolecular basis of agonism and antagonism in the oestrogen receptorNature199738966527537589338790
   PubMed Web of Science ®Google Scholar
• DanielianPSWhiteRLeesJAParkerMGIdentification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptorsEMBO J1992113102510331372244
   PubMed Web of Science ®Google Scholar
• ShiauAKBarstadDLoriaPMThe structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifenCell19989579279379875847
   PubMed Web of Science ®Google Scholar
• KallenJSchlaeppiJMBitschFEvidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alphaJ Biol Chem200427947493304933715337744
   PubMed Web of Science ®Google Scholar
• SuetsugiMSuLKarlsbergKYuanYCChenSFlavone and isoflavone phytoestrogens are agonists of estrogen-related receptorsMol Cancer Res200311398199114638870
   PubMed Web of Science ®Google Scholar
• CowardPLeeDHullMVLehmannJM4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gammaProc Natl Acad Sci U S A200198158880888411447273
   PubMed Web of Science ®Google Scholar
• LuoJMSladekRCarrierJBaderJARichardDGiguèreVReduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alphaMol Cell Biol200323227947795614585956
   PubMed Web of Science ®Google Scholar
• HussJMImahashiKIDufourCRThe nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overloadCell Metab200761253717618854
   PubMed Web of Science ®Google Scholar
• BonnelyeEVanackerJMDittmarTThe ERR-1 orphan receptor is a transcriptional activator expressed during bone developmentMol Endocrinol19971179059169178750
   PubMedGoogle Scholar
• DelhonIGutzwillerSMorvanFAbsence of estrogen receptor-related-alpha increases osteoblastic differentiation and cancellous bone mineral densityEndocrinology2009150104463447219608650
   PubMed Web of Science ®Google Scholar
• TeyssierCGalletMRabierBAbsence of ERR alpha in female mice confers resistance to bone loss induced by age or estrogen-deficiencyPLoS One2009411
   Web of Science ®Google Scholar
• PuigserverPWuZDParkCWGravesRWrightMSpiegelmanBMA cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesisCell19989268298399529258
   PubMed Web of Science ®Google Scholar
• YoonJCPuigserverPChenGXControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1Nature2001413685213113811557972
   PubMed Web of Science ®Google Scholar
• HussJMTorraIPStaelsBGiguèreVKellyDPEstrogen-related receptor alpha directs peroxisome proliferator-activated receptor at signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscleMol Cell Biol200424209079909115456881
   PubMed Web of Science ®Google Scholar
• MoothaVKHandschinCArlowDErralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscleProc Natl Acad Sci U S A2004101176570657515100410
   PubMed Web of Science ®Google Scholar
• KresslerDSchreiberSNKnuttiDKralliAThe PGC-1-related protein PERC is a selective coactivator of estrogen receptor alphaJ Biol Chem200227716139181392511854298
   PubMed Web of Science ®Google Scholar
• LinJDPuigserverPDonovanJTarrPSpiegelmanBMPeroxisome proliferator-activated receptor gamma coactivator 1 beta (PGC-1 beta), a novel PGC-1-related transcription coactivator associated with host cell factorJ Biol Chem200227731645164811733490
   PubMed Web of Science ®Google Scholar
• Pérez-SchindlerJSummermatterSSalatinoSThe corepressor NCoR1 antagonizes PGC-1α and estrogen-related receptor α in the regulation of skeletal muscle function and oxidative metabolismMol Cell Biol201232244913492423028049
   PubMed Web of Science ®Google Scholar
• CastetAHerledanABonnetSJalaguierSVanackerJMCavaillesVReceptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genesMol Endocrinol20062051035104716439465
   PubMedGoogle Scholar
• BarryJBGiguèreVEpidermal growth factor-induced signaling in breast cancer cells resufts in selective target gene activation by orphan nuclear receptor estrogen-related receptor alphaCancer Res200565146120612916024613
   PubMed Web of Science ®Google Scholar
• AriaziEAKrausRJFarrellMLJordanVCMertzJEEstrogen-related receptor alpha 1 transcriptional activities are regulated in part via the ErbB2/HER2 signalling pathwayMol Cancer Res200751718517259347
   PubMed Web of Science ®Google Scholar
• ChangCYKazminDJasperJSKunderRZuercherWJMcDonnellDPThe metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancerCancer Cell201120450051022014575
   PubMed Web of Science ®Google Scholar
• TremblayAMWilsonBJYangXJGiguèreVPhosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motifMol Endocrinol200822357058418063693
   PubMedGoogle Scholar
• WilsonBJTremblayAMDebloisGSylvain-DroletGGiguèreVAn acetylation switch modulates the transcriptional activity of estrogen-related receptor alphaMol Endocrinol20102471349135820484414
   PubMedGoogle Scholar
• DwyerMAJosephJDWadeHEWNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migrationCancer Res201070229298930820870744
   PubMed Web of Science ®Google Scholar
• ZhaoYYLiYPLouGYMiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cellsPLoS One201276
   Web of Science ®Google Scholar
• SteinRAChangCYKazminDAEstrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancerCancer Res200868218805881218974123
   PubMed Web of Science ®Google Scholar
• DebloisGChahrourGPerryMCSylvain-DroletGMullerWJGiguèreVTranscriptional control of the ERBB2 amplicon by ERRalpha and PGC-1 beta promotes mammary gland tumorigenesisCancer Res20107024102771028720961995
   PubMed Web of Science ®Google Scholar
• FradetASorelHBouazzaLDual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerinCancer Res201171175728573821734015
   PubMed Web of Science ®Google Scholar
• DebloisGHallJAPerryMCGenome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneityCancer Res200969156149615719622763
   PubMed Web of Science ®Google Scholar
• ChenEIHewelJKruegerJSAdaptation of energy metabolism in breast cancer brain metastasesCancer Res20076741472148617308085
   PubMed Web of Science ®Google Scholar
• TirabyCHazenBCGantnerMLKralliAEstrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growthCancer Res20117172518252821339306
   PubMed Web of Science ®Google Scholar
• AriaziEAClarkGMMertzJEEstrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancerCancer Res200262226510651812438245
   PubMed Web of Science ®Google Scholar
• SuzukiTMikiYMoriyaTEstrogen-related receptor a in human breast carcinoma as a potent prognostic factorCancer Res200464134670467615231680
   PubMed Web of Science ®Google Scholar
• KallenJLattmannRBeerliRCrystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanismJ Biol Chem200728232232312323917556356
   PubMed Web of Science ®Google Scholar
• PatchRJSearleLLKimAJIdentification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agentsJ Med Chem201154378880821218783
   PubMed Web of Science ®Google Scholar
• XuSZhuangXPanX1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor αJ Med Chem201356114631464023656512
   PubMed Web of Science ®Google Scholar
• HyattSMLockamyELSteinRAOn the intractability of estrogen-related receptor alpha as a target for activation by small moleculesJ Med Chem200750266722672418052088
   PubMed Web of Science ®Google Scholar
• PengLGaoXDuanLRenXWuDDingKIdentification of pyrido[1,2-α]pyrimidine-4-ones as new molecules improving the transcriptional functions of estrogen-related receptor αJ Med Chem201154217729773321958216
   PubMed Web of Science ®Google Scholar
• YangCChenSTwo organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor alpha-1 orphan receptorCancer Res199959184519452410493499
   PubMed Web of Science ®Google Scholar
• WangJJFangFHuangZYWangYFWongCWKaempferol is an estrogen-related receptor alpha and gamma inverse agonistFEBS Lett2009583464364719171140
   PubMed Web of Science ®Google Scholar
• BuschBBStevensWCMartinRIdentification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alphaJ Med Chem200447235593559615509154
   PubMed Web of Science ®Google Scholar
• LanvinOBiancoSKersualNChalbosDVanackerJMPotentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790J Biol Chem200728239283282833417631492
   PubMed Web of Science ®Google Scholar
• WangJWangYWongCOestrogen-related receptor alpha inverse agonist XCT-790 arrests A549 lung cancer cell population growth by inducing mitochondrial reactive oxygen species productionCell Prolif201043210311320447055
   PubMed Web of Science ®Google Scholar
• ChenLHWongCWEstrogen-related receptor alpha inverse agonist enhances basal glucose uptake in myotubes through reactive oxygen speciesBiol Pharm Bull20093271199120319571385
   PubMed Web of Science ®Google Scholar
• NieYHWongCWSuppressing the activity of ERR alpha in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal glucose uptakeJ Cell Mol Med2009139B3051306018544047
   PubMed Web of Science ®Google Scholar
• WuFWangJJWangYFKwokTTKongSKWongCWEstrogen-related receptor alpha (ERRalpha) inverse agonist XCT-790 induces cell death in chemotherapeutic resistant cancer cellsChem Biol Interact2009181223624219464277
   PubMed Web of Science ®Google Scholar
• BiancoSLanvinOTribolletVMacariCNorthSVanackerJMModulating estrogen receptor-related receptor-alpha activity inhibits cell proliferationJ Biol Chem200928435232862329219546226
   PubMed Web of Science ®Google Scholar
• ChisamoreMJMosleyRTCaiSJIdentification of small molecule estrogen-related receptor alpha-specific antagonists and homology modeling to predict the molecular determinants as the basis for selectivity over ERR beta and ERR gammaDrug Dev Res2008694203218
   Web of Science ®Google Scholar
• ChisamoreMJCunninghamMEFloresOWilkinsonHAChenJDCharacterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cellsPlos One200945
   Web of Science ®Google Scholar
• ChisamoreMJWilkinsonHAFloresOChenJDEstrogen-related receptor-alpha antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenograftsMol Cancer Ther20098367268119276159
   PubMed Web of Science ®Google Scholar
• WangYFFangFWongCWTroglitazone is an estrogen-related receptor alpha and gamma inverse agonistBiochem Pharmacol2010801808520298676
   PubMed Web of Science ®Google Scholar
• FioriJLSanghviMO’ConnellMPKrzysik-WalkerSMMoaddelRBernierMThe cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor alpha proteinBr J Pharmacol201116431026104021449913
   PubMed Web of Science ®Google Scholar
• Krzysik-WalkerSMGonzález-MariscalIScheibye-KnudsenMIndigFEBernierMThe biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERR alphaMol Pharmacol201383115716623066093
   PubMed Web of Science ®Google Scholar
• DuellmanSJCalaoaganJMSatoBGA novel steroidal inhibitor of estrogen-related receptor alpha (ERR alpha)Biochem Pharmacol201080681982620513360
   PubMed Web of Science ®Google Scholar
• ChaoWRAminKShiYHSR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivoAngiogenesis201114111621104121
   PubMed Web of Science ®Google Scholar
• GaillardSGrasfederLLHaeffeleCLReceptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairsMol Cell200624579780317157261
   PubMed Web of Science ®Google Scholar
• ZhangZPTengCTEstrogen receptor alpha and estrogen receptor-related receptor alpha 1 compete for binding and coactivatorMol Cell Endocrinol20011721–222323311165056
   PubMed Web of Science ®Google Scholar
• KrausRJAriaziEAFarrellMLMertzJEEstrogen-related receptor alpha 1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cellsJ Biol Chem200227727248262483411986328
   PubMed Web of Science ®Google Scholar
• WatanabeAKinoshitaYHosokawaKMoriTYamaguchiTHonjoHFunction of estrogen-related receptor alpha in human endometrial cancerJ Clin Endocrinol Metab20069141573157716464951
   PubMed Web of Science ®Google Scholar
• MoothaVKLindgrenCMErikssonKFPGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNat Genet200334326727312808457
   PubMed Web of Science ®Google Scholar